Stock Market News in real time

CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

September 04, 2022 at 04:48 am EDT

HONG KONG (Reuters) - CanSino Biologics Inc's inhaled version of its adenovirus-vectored COVID-19 vaccine has been approved by China's medical products regulator for emergency use as a booster, the company said in a filing on Sunday.

(Reporting by Twinnie Siu; Editing by Edmund Klamann)

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	CANSINO BIOLOGICS INC.	18.36 HKD	+1.66%	+3.61%	1.06B

Headlines

Growth at a reasonable price

Wheat climbs with dry weather fears continuing

April 25, 2024 at 05:54 pm EDT

Capital One's first-quarter profit jumps on interest income boost

April 25, 2024 at 05:52 pm EDT

MORNING BID ASIA-Bank of Japan center stage, US tech supports

April 25, 2024 at 05:45 pm EDT

As demand for US LNG booms, one plant struggles to stay online

April 25, 2024 at 05:42 pm EDT

Wall Street: lost almost 2% initially, ended at -0.6%.

April 25, 2024 at 05:25 pm EDT

News Highlights : Top Global Markets News of the Day - Thursday at 5 PM ET

April 25, 2024 at 05:15 pm EDT

News Highlights : Top Global Markets News of the Day - Thursday at 7 PM ET

April 25, 2024 at 05:15 pm EDT

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

April 25, 2024 at 04:48 pm EDT

BGC Group takes aim at 'heavyweight champ' CME exchange

April 25, 2024 at 04:45 pm EDT

All our articles

Stock Market News in real time

CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

Stocks mentioned in the article

Headlines

Most Read News